• Recursion Pharmaceuticals’ stock rises 8% in pre-market to $5.08 after positive trial results. • The Phase 1B/2 TUPELO trial indicates significant reductions in polyp burden for REC-4881, enhancing ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

This AI company isn't yet living up to the hype. Let's discuss Recursion Pharmaceuticals' performance over the past four years and whether the company can deliver solid returns in the future. It can ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to beat earnings when it reports second-quarter 2025 results on Aug. 5 ...

BOSTON--(BUSINESS WIRE)--Factorial Inc. (Factorial), an industry leader in solid-state battery technology, today announced the shipment of its first solid-state lithium-metal battery cells for drone ...

The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital. The company reported ...

Can a small Massachusetts start-up perfect a battery that would make electric vehicles cheaper and more convenient than conventional cars? Can a small Massachusetts start-up perfect a battery that ...

Stellantis and Factorial Energy made a major announcement for EV batteries on April 24, 2025. The companies reported that they’ve successfully validated a powerful new solid-state battery cell, ...

Stellantis and Factorial Energy successfully validated automotive-sized solid-state battery cells with 375Wh/kg energy density, a major step toward commercial use Breakthrough FEST® technology enables ...

In a move that signals a transformative shift in the electric vehicle landscape, Stellantis N.V. and Factorial Energy announced today the successful validation of automotive-sized solid-state battery ...